-
Healthcare
-

Commissioning Capability at Critical Low After Decade of Under-Investment

By
Distilled Post Editorial Team

Strategic planning skills ‘steadily eroded’ as authorities admit critical shortage of commercial and analytical expertise

National health leaders have acknowledged that the system’s capacity to plan, commission, and purchase care for millions of patients has reached a critical low point. After fifteen years of repeated structural reorganisation and sustained funding pressure, senior figures have conceded that the expertise required to manage multi-billion pound budgets has been severely depleted.

The admission is notable for its candour. Officials responsible for overseeing regional health bodies have confirmed that skills in economic forecasting, commercial negotiation, and data analysis, the core functions of effective commissioning, have been steadily eroded to the point where they can no longer be taken for granted. The consequences, they warn, are not theoretical. They are already visible in how care is planned and delivered across England.

The acknowledgement arrives at a moment of considerable internal contradiction. Regional health bodies have been handed an expansive mandate to transform local services and shift the system toward what policymakers describe as “population health management”: a long-term, preventive approach to reducing demand on hospitals. At the same time, those same bodies are operating under instructions to reduce their administrative running costs by between 30 and 50 per cent.

The tension between these two directives has produced what several senior figures have described as a crisis of confidence within commissioning teams. Staff report feeling isolated and under-resourced. Many lack the authority or the analytical tools necessary to challenge decisions made by large hospital trusts or independent providers. The result is a planning function that is, in key areas, struggling to fulfil its basic purpose.

The specific skills lost to the system over this period are well-documented. In economic forecasting, the health service’s ability to model long-term population demand and project future cost pressures has diminished substantially. Decisions that once rested on detailed actuarial analysis are increasingly made on thinner evidence.

In commercial negotiation, the departure of experienced contract managers; many of whom left during successive reorganisations, has left regional bodies less equipped to secure value-for-money agreements with private and third-sector providers. Where expertise is absent, providers hold the stronger hand.

The erosion of data analytics capacity compounds both problems. Turning raw patient data into actionable commissioning decisions requires technical skills that have become scarce. Without them, spending choices risk being driven by history and precedent rather than current or projected need.

For patients and taxpayers, the practical consequences of weakened commissioning are measurable. Waiting lists become harder to manage when the planning infrastructure required to match capacity to demand is insufficient. Regional variation in access to treatment — the so-called postcode lottery — tends to widen when central oversight loses its analytical grip. And in contract management, gaps in expertise create conditions in which public funds are spent without adequate scrutiny of what they are buying.

None of these outcomes is inevitable. Each reflects, to a significant degree, decisions made about where to invest and where to cut over an extended period.

Later this year, NHS England is expected to launch a workforce development programme directed at rebuilding commissioning capability. The initiative carries a budget of £7 million and is intended to deliver targeted retraining across the areas identified as most critically depleted.

The scale of the investment relative to the scale of the problem is open to scrutiny. Fifteen years of accumulated skill loss, compounded by structural disruption and sustained underfunding of management capacity, is not straightforwardly addressed by a single retraining programme. Whether £7 million is sufficient to reverse a systemic decline, or whether it represents a first step toward a longer, more expensive repair — is a question the programme’s designers have not yet answered in full.

The condition of the health service is routinely assessed through the metrics most visible to the public: waiting times, bed numbers, staffing levels. These are legitimate and important measures. But the current situation draws attention to a different layer of the system: one less visible but no less consequential.

The hospitals exist. The staff, under pressure, continue to work. What has been allowed to decline is the intellectual infrastructure that determines how resources are allocated, how contracts are written, and how future demand is anticipated. Until that capacity is restored, the ambitions set for the health service will remain difficult to achieve, regardless of how much is spent on its more visible components.​​​​​​​​​​​​​​​​